Summary:
A double-blind, randomized, placebo-controlled, parallel group, multi-site study to evaluate the clinical equivalence of lubiprostone 24mcg capsules (anchen pharmaceuticals, inc.) with amitiza (lubiprostone) 24 mcg capsules (Sucampo Pharaceuticals, Inc.) in the treatment of chronic idiopathic constipation.
Qualified Participants Must:
• Be 18 years of age or older
Qualified Participants May Receive:
Study drug or placebo, physical exam and laboratory testing.